Genprex Inc
Change company Symbol lookup
Select an option...
GNPX Genprex Inc
CMG Chipotle Mexican Grill Inc
CMCSA Comcast Corp
CLGX Corelogic Inc
CIO City Office REIT Inc
CHKP Check Point Software Technologies Ltd
CHK Chesapeake Energy Corp
CHH Choice Hotels International Inc
CERN Cerner Corp
CEO CNOOC Ltd
Go

Health Care : Biotechnology |
Company profile

Genprex, Inc. is a clinical stage gene therapy company. The Company is focused on developing cancer-based upon its novel proprietary technology platform, including its initial product candidate, Oncoprex, immunogene therapy, or Oncoprex. The Company’s Oncoprex is lead product candidate, is the subject of an ongoing Phase I/II clinical trials at The University of Texas MD Anderson Cancer Center in patients with late stage non-small cell lung cancer, or NSCLC. Oncoprex gene therapy platform may also be effective with respect to other types of cancer, including breast, head and neck, renal cell (kidney), soft tissue cancer. The Company’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles. The Company’s Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis.

Closing Price
$4.28
Day's Change
1.54 (56.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.75
Day's Low
3.15
Volume
(Heavy Day)
Volume:
83,976,853

10-day average volume:
13,833,708
83,976,853

Display:

Providers:

UpdateCancel
7 providers

No news found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.